Highlight selection of radiochemistry and radiopharmacy developments by editorial board




Aime Silvio, Al-Qahtani Mohammed, Behe Martin, Bormans Guy, Carlucci Giuseppe, DaSilva Jean N., Decristoforo Clemens, Duatti Adriano, Elsinga Philip H., Kopka Klaus, Li Xiang-Guo, Liu Zhibo, Mach Robert H., Middel Oskar, Passchier Jan, Patt Marianne, Penuelas Ivan, Rey Ana, Scott Peter J. H., Todde Sergio, Toyohara Jun, Vugts Danielle, Zhi Yang

PublisherSPRINGERNATURE

2021

EJNMMI Radiopharmacy and Chemistry

EJNMMI RADIOPHARMACY AND CHEMISTRY

EJNMMI RADIOPHARM CH

ARTN 13

6

19

2365-421X

DOIhttps://doi.org/10.1186/s41181-021-00128-x

https://ejnmmipharmchem.springeropen.com/articles/10.1186/s41181-021-00128-x

https://research.utu.fi/converis/portal/detail/Publication/69169496



Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Results

This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.


Last updated on 2024-26-11 at 20:30